These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 3313791
1. [Controlled study of a new anti-allergic agent, N-acetyl-aspartyl- glutamic acid (NAAGA), in the local treatment of pollinosis]. Girard JP, Weibel MA. Ther Umsch; 1987 Aug; 44(8):607-11. PubMed ID: 3313791 [No Abstract] [Full Text] [Related]
2. [NAAGA and cromoglycate. A comparison in the treatment of seasonal allergic rhinitis]. Datz B, Sieger C, Weibel MA. Laryngol Rhinol Otol (Stuttg); 1988 Jun; 67(6):300-3. PubMed ID: 3136279 [Abstract] [Full Text] [Related]
5. The protective effect of N-acetyl-aspartyl-glutamate (NAAGA) against nasal obstruction provoked by antigen in allergic rhinitis. Magyar P, Györi Z, Márk Z, Hutás I. Allergy; 1993 Nov; 48(8):631-3. PubMed ID: 8116863 [Abstract] [Full Text] [Related]
6. [Evaluation of the efficacy of the magnesium salt of N-acetyl-aspartyl-glutamic acid in the treatment of acute rhinitis]. Miadonna A, Tedeschi A, Parravicini P, Lorini M. Clin Ter; 1989 Nov 15; 131(3):173-6. PubMed ID: 2575479 [Abstract] [Full Text] [Related]
7. A preliminary evaluation of the effect of N-acetyl-aspartyl-glutamate on pollen nasal challenge as measured by rhinomanometry and symptomatology. Ghaem A. Allergy; 1987 Nov 15; 42(8):626-30. PubMed ID: 3425862 [Abstract] [Full Text] [Related]
8. [Effectiveness and tolerance of the C3 convertase inhibitor, N-acetyl-aspartyl-magnesium glutamate in perennial rhinitis. Results of a double-blind, placebo-controlled study]. Harnest U, Kiehn R, Sieger C, Weibel MA. Arzneimittelforschung; 1989 Feb 15; 39(2):273-5. PubMed ID: 2659003 [Abstract] [Full Text] [Related]
13. A comparison of an aqueous and a pressurized nasal spray of beclomethasone dipropionate in the management of seasonal rhinitis. Harries MG, Anderson PB, Gibson GJ, Hof ZE, Baggott PJ. Pharmatherapeutica; 1984 Feb 15; 3(9):623-5. PubMed ID: 6374683 [Abstract] [Full Text] [Related]
15. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May 15; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
16. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA. Denis D, Bloch-Michel E, Verin P, Sebastiani A, Tazartes M, Helleboid L, Di Giovanni A, Lecorvec M. Br J Ophthalmol; 1998 Oct 15; 82(10):1135-8. PubMed ID: 9924299 [Abstract] [Full Text] [Related]
17. Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis. Chandra RK, Heresi G, Woodford G. Ann Allergy; 1982 Sep 15; 49(3):131-4. PubMed ID: 6126145 [Abstract] [Full Text] [Related]
19. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E. Curr Med Res Opin; 2009 Jun 15; 25(6):1393-401. PubMed ID: 19419338 [Abstract] [Full Text] [Related]
20. Two-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis. Nuutinen J, Ruoppi P, Sorri M, Suonpää J, Vainio-Mattila J. Rhinology; 1983 Jun 15; 21(2):165-72. PubMed ID: 6351231 [Abstract] [Full Text] [Related] Page: [Next] [New Search]